Prostate Cancer News

Get the latest cancer news and research. Sort by cancer type or read the current headlines to learn what’s happening in the science of cancer detection and treatment, as well as healthy living tips for dealing with cancer.

Nov

06

New Synthetic Molecules Trigger Immune Response To HIV And Prostate Cancer

Researchers at Yale University have developed synthetic molecules capable of enhancing the body's immune response to HIV and HIV-infected cells, as well as to prostate cancer cells. Their findings, published online in the Journal of the American Chemical Society, could lead to novel therapeutic approaches for these diseases.

Nov

06

Antipsychotic Drugs Fight Cancer

Drugs used to treat psychiatric disorders are highly effective at killing cancer cells, opening up potential new lines of treatments. Dr Louise Lurze-Mann of the University of NSW School of Biotechnology and Biomolecular Sciences was talking with psychiatric researchers at the University of Queensland when they mentioned that people with diseases like schizophrenia appear to have low rates of cancer, despite being more inclined to smoke than the general population.

Nov

05

Studies Show Early Promise Of MannKind's Cancer Immunotherapy Program In Melanoma, Prostate Cancer And Other Solid Malignancies

Results of two phase 1 studies demonstrate that the novel, investigational cancer vaccines MKC1106-MT and MKC1106-PP are well-tolerated and show encouraging immune response rates and objective tumor response in advanced melanoma, prostate cancer and other solid malignancies, setting the stage for phase 2 studies. The data are being presented at the International Society for Biological Therapy of Cancer 2009 Annual Meeting.

Nov

05

Sweet Potatoes Make For A Hearty Soup Base

It's a safe bet to presume there are soup recipes in today's column because it's colder, furnaces are running and it just seems like a fall thing to do.

Nov

05

Newly Found Molecule Disrupts Cancer Cells

U.S. scientists say they have discovered a small molecule that inhibits the actions of a protein cancer cells require for survival. The researchers said they determined the molecule, called PES, inhibits a type of protein called a heat-shock protein that helps cells survive heat, lack of nutrients and other cell-damaging conditions.

Nov

05

Alternatively Spliced Tissue Factor Identified As Promising New Biomarker For Aggressive Cancers

A recently discovered form of the protein that triggers blood clotting may play a key role in the molecular mechanisms leading to the growth of certain metastatic cancers, according to new research reported by an international team of scientists.

Nov

04

Stuffed Acorn Squash Makes A Hearty Entree

Mollie Katzen's latest cookbook urges beginners to take on her challenge with easy recipes, such as this acorn squash entree. Use plain raw almonds, not roasted or salted, Katzen writes, and don't chop them too fine. You can cook the rice and bake the acorn squash at the same time.

Nov

04

Light Stews Still Hearty: Reduce Fat And Salt In Fall Soups

If you're watching your weight, soup can be deceptive. What could be more harmless for lunch or a light dinner? Not so fast. Depending on the recipe, some soups are full of cream and cheese, or sometimes worse, they start with a roux. In place of cream and butter, add flavor to soup with lots of vegetables, beef broth and dried and fresh herbs.

Nov

03

Low Cholesterol May Shrink Risk For High-Grade Prostate Cancer

Men with lower cholesterol are less likely than those with higher levels to develop high-grade prostate cancer - an aggressive form of the disease with a poorer prognosis, according to results of a Johns Hopkins collaborative study. In a prospective study of more than 5,000 U.S. men, epidemiologists say they now have evidence that having lower levels of heart-clogging fat may cut a man's risk of this form of cancer by nearly 60 percent.

Nov

02

Short-Term Hormone Therapy Added To Radiation Increases Survival For Medium-Risk, But Not Low-Risk, Prostate Cancer Patients

Short-term hormone therapy given prior to and during radiation treatment to medium-risk prostate cancer patients increases their chance of living longer, compared to those who receive radiation alone, however there is no significant benefit for low-risk patients, according to the largest randomized study of its kind presented at the plenary session November 2, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Page(s): 1 2 3 4 5 6 7 ...201202 Next 

We care about your feedback. Let us know how we can improve your CancerCompass experience.